2003
DOI: 10.1002/path.1316
|View full text |Cite
|
Sign up to set email alerts
|

Low‐ and high‐risk CIN 1 and 2 lesions: prospective predictive value of grade, HPV, and Ki‐67 immuno‐quantitative variables

Abstract: The aim of this study was to evaluate in small cervical biopsies (non-cone, non-large loop excision of the transformation zone, LLETZ) the prognostic value of both routinely assessed and reviewed cervical intraepithelial neoplasia (CIN) grades 1 and 2, oncogenic human papillomavirus (onco-HPV) DNA (HPV status) and Ki-67 immuno-quantitative features for the prediction of progression. In biopsies from 44 CIN patients (the learning set), subjective CIN grade, onco-HPV by PCR, and Ki-67 immuno-quantitative feature… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
29
0
1

Year Published

2004
2004
2010
2010

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 47 publications
(37 citation statements)
references
References 25 publications
1
29
0
1
Order By: Relevance
“…All HPV subtypes detected in the current study belonged to the high-risk group and these results were found to be in keeping with previous findings showing that HPV-16 was the most frequent HPV subtype detected in cervical lesions, followed by the HPV-52 subtype. 24 Because the advantages of HPV testing have been established in cervical carcinoma screening, known biomarkers such as Ki-67 25 and MN 26 antigen have been found to be unsatisfactory in terms of their specificity and sensitivity in primary screening for cervical carcinoma. In 1998, Sano et al clearly demonstrated the overexpression of p16 in CIN lesions and nearly all cervical carcinomas.…”
Section: Discussionmentioning
confidence: 99%
“…All HPV subtypes detected in the current study belonged to the high-risk group and these results were found to be in keeping with previous findings showing that HPV-16 was the most frequent HPV subtype detected in cervical lesions, followed by the HPV-52 subtype. 24 Because the advantages of HPV testing have been established in cervical carcinoma screening, known biomarkers such as Ki-67 25 and MN 26 antigen have been found to be unsatisfactory in terms of their specificity and sensitivity in primary screening for cervical carcinoma. In 1998, Sano et al clearly demonstrated the overexpression of p16 in CIN lesions and nearly all cervical carcinomas.…”
Section: Discussionmentioning
confidence: 99%
“…290 The co-application of vidarabine and podophyllin over six treatments resulted in the cytological and histological regression of lesions and the disappearance of HPV 16 and 18 DNA in 17 of 21 (81%) of women with CIN I-II. 291 Vidarabine is a DNA polymerase inhibitor that suppresses HPV gene expression in immortalized human cervical keratinocytes and cervical cancer cell lines in vitro.…”
Section: Systemic Interferon-α 2b + Isotretinoinmentioning
confidence: 99%
“…The decreased availability of the functioning Rb protein due to the over-expression of E7 polypeptide, not only leads to p16 overexpression, but also explains the higher expression Ki-67 protein [56]. To achieve precise grading of LSIL versus HSIL lesions following Ki-67 antigen staining, Kruse et al [57] suggested to count the number of positive nuclei per 100 μm epithelium thickness starting from the parabasal zone (stratification index). The authors in question found a positive correlation (of 83%) with the original histological classification based on H.E.…”
Section: Overexpression Of the P16/ink4a Polypeptide In Hpv Transformmentioning
confidence: 99%